Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease

被引：0
|
作者：
Saleem, R. [1 ]
Dubois, P. [1 ]
Chung-Faye, G. [1 ]
Bjarnason, I. [1 ]
Hayee, B. [1 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60602-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P482
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [21] Unaffected ileal transcriptomics in Crohn's disease is associated with the response to anti-TNF therapy
    Lee, H. S.
    Lee, Y.
    Baek, J.
    Kim, Y.
    Park, S.
    Jung, S.
    Kim, K. K.
    Hwang, S. W.
    Lee, J. L.
    Park, S. H.
    Yang, S. K.
    Han, B.
    Song, K.
    Yoon, Y. S.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I157 - I158
  • [22] Hidradenitis suppurativa associated with Crohn’s disease and spondyloarthropathy: response to anti-TNF therapy
    Maria Roussomoustakaki
    Philippos Dimoulios
    Constantinos Chatzicostas
    Heraklis D. Kritikos
    John Romanos
    John G. Panayiotides
    Elias A. Kouroumalis
    Journal of Gastroenterology, 2003, 38 : 1000 - 1014
  • [23] Infliximab but not adalimumab drug levels predict faecal calprotectin response in Inflammatory Bowel Disease patients on dose-intensified anti-TNF therapy
    Noack, S.
    Little, R.
    Vaz, K.
    Ward, M.
    Sparrow, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S471 - S472
  • [24] Addition of thiopurine can recapture lost response to anti-TNF monotherapy in Crohn's disease
    Ong, David E.
    Lust, Mark
    Kamm, Michael A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 113 - 113
  • [25] Addition of thiopurine can recapture lost response to anti-tnf monotherapy in Crohn's disease
    Ong, David
    Lust, Mark
    Kamm, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 158 - 158
  • [26] Effect of anti-TNFα therapy with daily physical activity in patients with Crohn's disease
    Lucca, F. A.
    Malaguti, C.
    Cabalzar, A. L.
    Chebli, L. A.
    Ribeiro, T. C. R.
    Gaburri, P. D.
    Chebli, J. M. F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S344 - S344
  • [27] The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease
    Mascheretti, S
    Schreiber, S
    PHARMACOGENOMICS, 2004, 5 (05) : 479 - 486
  • [28] WEIGHT ADJUSTED ANTI-TNF THERAPY FAVOURS OBESE PATIENTS WITH CROHN'S DISEASE
    Bhalme, M.
    Sharma, A.
    Keld, R.
    Makin, A.
    Willert, R.
    Campbell, S.
    GUT, 2012, 61 : A228 - A228
  • [29] Use of Anti-TNF Therapy in Patients With Crohn's Disease Complicated by an Abdominal Phlegmon
    O'Donnell, Sarah
    Chawla, Tanya P.
    Nguyen, Geoffrey C.
    Silverberg, Mark S.
    Steinhart, A. Hillary
    Croitoru, Kenneth
    GASTROENTEROLOGY, 2015, 148 (04) : S459 - S459
  • [30] Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease
    Aggarwal, Divya
    Limdi, Jimmy K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 13 - 19
12345